Author Topic: (Abst.) Ocrelizumab depletes T-lymphocytes more than rituximab in MS  (Read 57 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9821
  • MS diagnosed 1980
  • Location: Pacific Northwest
From PubMed (February 9, 2021)--"Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis":


https://pubmed.ncbi.nlm.nih.gov/33556652/
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
2 Replies
457 Views
Last post December 26, 2016, 02:47:31 pm
by agate
0 Replies
135 Views
Last post August 04, 2018, 08:32:29 am
by agate
0 Replies
26 Views
Last post November 01, 2022, 09:38:58 pm
by agate
4 Replies
2364 Views
Last post November 27, 2023, 04:18:36 pm
by agate
0 Replies
15 Views
Last post December 04, 2023, 11:04:57 am
by agate